Combination therapy in pulmonary arterial hypertension.

Link to article at PubMed

Related Articles

Combination therapy in pulmonary arterial hypertension.

Clin Chest Med. 2013 Dec;34(4):841-55

Authors: Pugh ME, Hemnes AR, Robbins IM

Abstract
Despite major advances in understanding the mechanisms of disease and development of specific drug therapy, pulmonary arterial hypertension (PAH) remains a progressive, fatal disease. At present there are 3 classes of drug therapy for PAH: prostaglandins, endothelin receptor antagonists, and phosphodiesterase-5 inhibitors. To maximize therapeutic benefit, and according to national and international guidelines, many patients are treated with combinations of these medications. This review presents a detailed account of the published data on the use of combination therapy in PAH. There are few randomized, placebo-controlled trial data to strongly support efficacy of most combination therapy, particularly oral combination therapy.

PMID: 24267308 [PubMed - in process]

Leave a Reply

Your email address will not be published.

Combination therapy in pulmonary arterial hypertension.

Link to article at PubMed

Related Articles

Combination therapy in pulmonary arterial hypertension.

Clin Chest Med. 2013 Dec;34(4):841-55

Authors: Pugh ME, Hemnes AR, Robbins IM

Abstract
Despite major advances in understanding the mechanisms of disease and development of specific drug therapy, pulmonary arterial hypertension (PAH) remains a progressive, fatal disease. At present there are 3 classes of drug therapy for PAH: prostaglandins, endothelin receptor antagonists, and phosphodiesterase-5 inhibitors. To maximize therapeutic benefit, and according to national and international guidelines, many patients are treated with combinations of these medications. This review presents a detailed account of the published data on the use of combination therapy in PAH. There are few randomized, placebo-controlled trial data to strongly support efficacy of most combination therapy, particularly oral combination therapy.

PMID: 24267308 [PubMed - in process]

Leave a Reply

Your email address will not be published.